AVPN Social Investment Forum Japan 2022
18 November 2022
Social Investment towards Sustainable Development Goals (SDGs) in Asia
Today, Asia Pacific faces an estimated annual funding gap of USD1.6 trillion to achieve the United Nations Sustainable Development Goals (SDGs) and impact capital will have to play a catalytic role in influencing markets and the state.
In this context, both public and private sectors are increasing their role, especially private finance has long been seen as key to bridging this gap and numerous actors have stepped in. These include philanthropic foundations, corporations, financial institutions, impact funds, intermediaries and impact organisations such as non-profits and social enterprises, and they are working toward sustainable development through significant social Innovation. In the past decade, AVPN’s members and partners in the region have come together to bring about transformative change in the region. We are now at a tipping point in accelerating SDGs action in Asia, and it is critical that we share a clear and ambitious vision for moving capital toward social impact in the next decade.
The International Finance Corporation (IFC) estimates that USD2.3 trillion is invested with the mandate of achieving positive impact as of 2020. East and Southeast Asia are one of the fastest growing regions for such investments, growing 23%, and more investors are expected to focus on this region over the next five years, according to the Global Impact Investing Network's investor (GIIN) survey.
Particularly in Japan, the impact investment market is growing, and according to a survey by the Japan National Advisory Board of The Global Steering Group for Impact Investment (GSG-NAB Japan), the outstanding investment balance of impact investments has grown from around JPY71.8 billion (approximately USD 652 million) in 2018 to around JPY 1320.4 billion (approximately USD12 billion) in 2021. This is due to the fact that asset management companies, insurance companies, and financial institutions are entering the impact investment market as new impact investment institutions. In addition to the increasing number of impact funds being established in Japan, a national advisory committee for impact investing has also been established. Also, a major Japanese financial institution recently announced "Japan Impact-driven Financing Initiative”, signalling a solid trajectory for impact investing.
For the first time in Japan, a key country in Asia where impact investing is thus accelerating, AVPN will host the Social Investment Forum in Japan on 18 November 2022 as an opportunity to discuss and share knowledge and best practices around social investments in gender, education and economic empowerment issues, which are key areas for achieving the SDGs.
This event is held in conjunction with the Asia Philanthropy Congress 2022, which is hosted by Nippon Foundation in partnership with AVPN and will be held on 19 November 2022 at the New Otani Hotel in Tokyo, Japan.
Provide new knowledge that contributes to the development of Asia's rapidly evolving social investment ecosystem
Disseminate trends and regional-relevant case studies of key players in Asia’s social investment market
Create new social investment opportunities by connecting companies, funds, and intermediary support organisations in Asia with investors and organisations outside the region
This year’s agenda has something to offer you
Principles of social investment for Asia
This session will be based on the principles and guiding frameworks that are relevant to and pertain to the Asia region. It will also touch upon cross-regional practices that could be followed by showcasing best practices and relevant case studies.
Innovative financing mechanisms to solve social issues in Southeast Asia
Impact Investments towards Education
This increase in the much needed investments has to be partially supported by the private sector. As Asia moves into a critical decade of action, there is waning interest in meaningfully investing in education. Education, while seen as important and necessary, does not receive the same urgency in investments as climate or health programmes.
Added to the challenges is the fact that measuring outcomes has to surface the nuances in education, and misalignment between stakeholders on what outcomes adequately capture education progress.
In a fragmented ecosystem of education actors, it is critical for impact investing to take a guiding role in shaping education-centric investments to ensure alignment, cohesiveness and innovation to facilitate collaboration between state and non-state actors, drive innovation in financing educational investments and shape outcome measurement and management for lasting and sustainable change in the sector.
Join us at the AVPN Social Investment Forum Japan 2022
The AVPN Social Investment Forum is an exclusive event for key leaders in the social investment domain including impact investors, business leaders, high net worth individuals (HNWI), family offices, corporate venture capitalists, crowdfunding management companies and asset management firms.
The invited speakers and delegates will hail from Asia Pacific, Europe and North America.
Owing to ongoing travel restriction into and out of Japan, the event will be on an invite-only basis with preference given to Catalyst and Vision tier members from AVPN’s network.
We work with the best partners
What do our members think about AVPN?
I’m really excited to come back to another AVPN convening because there are always really interesting people here and in-depth conversations to be had. There are philanthropists, impact investors, fund managers, academics – so there’s a broad range of people and I always find that we are setting up a lot of opportunities every time we come.
CEO at Investing in Women
I like the AVPN Regional Summit a lot as the themes are much more relevant to what we are seeing very specifically in this part of the world. Because we are all bound by our interests in these common themes, the atmosphere just feels a lot more intimate, a lot more familiar. I think that’s great when you attend a conference because the last thing you want to be is to be lost in a huge sea of people.
Founding Partner at Teja Ventures
The event was a great networking opportunity for us. We started and re-established relationships with various regional and global groups that seem interested in the way Morningtide adds value to the investment and business growth process. We saw a lot of value in the event itself.
Partner at Morningtide Capital Partners
Frequently Asked Questions
Owing to ongoing travel restriction into and out of Japan, the event will be on an invite-only basis with preference given to Catalyst and Vision tier members from AVPN’s network. To learn more about AVPN’s membership programme, please click here.
If you are interested in attending this event, please express your interest through this form.
Please note that only vaccinated individuals can attend the in-person event.
For enquiries, please contact us at email@example.com.
Please note that the travel restrictions are subject to change. Kindly refer to the Ministry of Foreign Affairs of Japan for the latest updates.
1. All relevant items described below should be listed on the certificate either in Japanese or English: Name, date of birth, product name or manufacturer of vaccines, vaccination date, number of COVID-19 vaccine doses (Note 1)
- (Note 1) COVID-19 vaccination certificates written in languages other than Japanese or English are considered as valid if the translation (Japanese/English) is attached and all the items are clearly identifiable.
2. The certificate should prove that at least two doses (As for JCOVDEN / Janssen, one dose is treated as two doses) of any of the COVID-19 vaccines described in the table a. below are inoculated, and any of the COVID-19 vaccines described in the table b. below is inoculated for the third vaccination or after.(Note 2)
- COVID-19 vaccines up to the second dose:
- COMIRNATY, Intramuscular injection / Pfizer
- Vaxzevria, Intramuscular injection / AstraZeneca (Note 3)
- Spikevax, Intramuscular injection / Moderna
- JCOVDEN / Janssen
- COVAXIN / Bharat Biotech
- Nuvaxovid, Intramuscular injection / Novavax (Note 3)
(Note 3) In applying measures based on New Border Measures (28), COMIRNATY manufactured by Fosun Pharma / BioNTech and Covishield / COVOVAX manufactured by the Serum Institute of India are treated as identical to COMIRNATY, Intramuscular injection / Pfizer and Vaxzevria, Intramuscular injection / AstraZeneca, Nuvaxovid, Intramuscular injection / Novavax respectively.
- COVID-19 vaccines for the third dose or after:
- COMIRNATY, Intramuscular injection / Pfizer (Note 4)
- Spikevax, Intramuscular injection / Moderna
- Nuvaxovid, Intramuscular injection / Novavax (Note 4)
- Vaxzevria, Intramuscular injection / AstraZeneca (Note 4)
- JCOVDEN / Janssen
- COVAXIN / Bharat Biotech (Note : To be recognized as valid after 0:00am(JST) July 31, 2022)
3. The certificate should be issued by an official body, such as a government.
Indoors: You do not need to wear a mask indoors when you are approximately 2 metres apart from others and when you are not talking. For more information, please visit the Ministry of Health, Labour and Welfare.